BME-Industry Grand Rounds: Immune Cell Therapy Solutions

David Hermanson & Jennifer Kang

Topics and speakers:

  • Non-Viral gene editing using TcBuster Transposon system for CAR T Therapy — David Hermanson, Director, Cell & Gene Therapy Applications, Bio-Techne
  • Exploring the frontiers of immune response: study of T cell media and behavior — Jennifer Kang, PhD Candidate, UMN Department of Biomedical Engineering


LinkedIn; Facebook; Twitter

Start date
Monday, Feb. 12, 2024, 3:35 p.m.
End date
Monday, Feb. 12, 2024, 4:30 p.m.

Virtual event open to all